RHINOCORT ALLERGY SPRAY OTC
Generic Name and Formulations:
Budesonide 32mcg; per nasal spray; scent- and alcohol-free.
McNeil Consumer Healthcare
Indications for RHINOCORT ALLERGY SPRAY:
To relieve symptoms of seasonal or perennial allergic rhinitis.
Adults and Children:
<6yrs: not recommended. 6–<12yrs: initially 1 spray in each nostril once daily; increase to 2 sprays per nostril once daily if no improvement; reduce to 1 spray in each nostril once daily when symptoms improve. ≥12yrs: use 2 sprays per nostril once daily; reduce to 1 spray in each nostril once daily when symptoms improve.
Do not use for treating the common cold or use more than recommended. Avoid eyes or mouth. Recent nose ulcers or surgery. Nose injury that has not healed. Eye infection. Glaucoma. Cataracts. Re-evaluate if no improvement after 2 weeks. Discontinue if exposed to chickenpox, measles, or tuberculosis, have symptoms of an infection (eg, persistent fever), change in vision, severe or frequent nosebleeds. Children 6–<12yrs: monitor and re-evaluate if treatment requires >2 months per year. Pregnancy. Nursing mothers.
Concomitant other steroid drugs for asthma, allergies, or skin rash.
Reduced growth velocity in children.
Spray—5mL (60 sprays), 8.4mL (120 sprays)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Clostridium Difficile Infection in Patients With Cancer — In the Clinic
- Can A Consortium of Hospitals Help To Reduce Drug Prices?
- NSCLC: Stratifying Patients With Complex EGFR Mutations
- Targeted and Immunotherapies for Metastatic Renal Cell Carcinoma
- FDA Approves Front-Line Brentuximab Vedotin Plus Chemotherapy for Hodgkin Lymphoma